Regulatory oversight of clinical trials in Africa: progress over the past 5 years

dc.contributor.author	Maïga, D.
dc.contributor.author	Akanmori, B.D.
dc.contributor.author	Chocarro, L.
dc.date.accessioned	2012-05-28T14:40:20Z
dc.date.accessioned	2017-10-16T12:59:46Z
dc.date.available	2012-05-28T14:40:20Z
dc.date.available	2017-10-16T12:59:46Z
dc.date.issued	2009
dc.description.abstract	Randomized controlled clinical trials represent the best way to establish the therapeutic or preventive value of medicines. This decade has seen a strong shift in the location of clinical trials from industrialized countries to developing countries, including many in Africa. However, without independent strong regulatory and ethical oversight of clinical trials the safety of research subjects, and scientific integrity of clinical data cannot be verified. This article draws up a portrait of clinical trials regulation in Africa in support of development of priority medicines, highlights challenges and presents the progress made by countries under WHO guidance over the past 5 years.	en_US
dc.identifier.citation	Vaccine 27(52): 7249-52	en_US
dc.identifier.uri	http://197.255.68.203/handle/123456789/1681
dc.language.iso	en	en_US
dc.publisher	Vaccine	en_US
dc.title	Regulatory oversight of clinical trials in Africa: progress over the past 5 years	en_US
dc.type	Article	en_US

Files

Now showing 1 - 1 of 1

Name:: Regulatory oversight of clinical trials in Africa Progress over the past 5 years.pdf
Size:: 123.27 KB
Format:: Adobe Portable Document Format
Description:

Now showing 1 - 2 of 2